Company Filing History:
Years Active: 2022-2023
Title: Innovations by Ashley Tehranchi
Introduction
Ashley Tehranchi is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of programmable nuclease compositions. With a total of two patents to his name, Tehranchi is recognized for his innovative approaches to detecting target nucleic acids associated with various diseases.
Latest Patents
Tehranchi's latest patents focus on programmable nuclease compositions and methods of use. These patents describe devices, systems, fluidic devices, kits, and methods for the detection of target nucleic acids linked to diseases, cancers, and genetic disorders. The technologies involve reagents that include a guide nucleic acid targeting a specific target nucleic acid, a programmable nuclease, and a single-stranded detector nucleic acid with a detection moiety. The target nucleic acids can indicate the presence of communicable diseases, cancers, or genetic disorders, as well as provide insights into genotypes, phenotypes, or ancestral origins.
Career Highlights
Tehranchi is currently employed at Mammoth Biosciences, Inc., where he continues to push the boundaries of genetic research and diagnostics. His work is instrumental in advancing the understanding and detection of various health conditions through innovative technologies.
Collaborations
Tehranchi collaborates with talented individuals in his field, including Janice Sha Chen and Andrew Besancon Lane. These partnerships enhance the research and development efforts at Mammoth Biosciences, Inc.
Conclusion
Ashley Tehranchi's contributions to biotechnology through his patents and work at Mammoth Biosciences, Inc. highlight his role as a leading inventor in the field. His innovative approaches to detecting target nucleic acids are paving the way for advancements in medical diagnostics and treatment.